Collins Opposes Trump’s DOJ Pick, Complicating Confirmation

The path to confirmation for acting Attorney General Todd Blanche has become significantly more challenging following a decisive statement from Senator Susan Collins, R-Maine. Despite surviving a crucial committee vote earlier in the week, Blanche’s nomination now faces heightened uncertainty as a key Republican voice has declared opposition, potentially jeopardizing his chances of leading the Department of Justice.

Collins Cites Political Erosion at DOJ

Senator Collins, who chairs the Senate Appropriations Committee, announced her intention to vote against Blanche’s confirmation, citing concerns about the increasing politicization of the Department of Justice. In a statement, she explained, “While I believe Mr. Blanche is a capable lawyer, the Department of Justice (DOJ) has become increasingly political.” She further elaborated that Blanche’s actions have “further eroded the Department’s independence,” forming the basis for her opposition.

Her decision comes after a thorough review of Blanche’s qualifications, including his performance during his confirmation hearing and his responses before the Senate Appropriations Committee. Collins detailed several specific points that influenced her vote, highlighting actions and proposals that have drawn criticism from within her own party.

Key Objections to Blanche’s Nomination

Among Senator Collins’s primary concerns were:

• Audit Immunity for Trump Family: Blanche’s approval of a “shield” designed to protect President Trump, his sons, and his family from IRS audits was a significant point of contention.
• The “Anti-Weaponization” Fund: The proposed nearly $2 billion fund, aimed at combating what is described as “weaponization” within government agencies, has reportedly unsettled several Republicans since its introduction earlier this year.
• Abortion Medication Stance: Collins pointed to Blanche’s commitments to anti-abortion organizations, specifically his pledge to seek ways to halt the mailing of abortion medication.
• Attempts to Indict Senators: His proposed indictments against Senators Mark Kelly, D-Ariz., and Elissa Slotkin, D-Mich., for what he termed “ill-advised, but constitutionally protected, videos encouraging resistance to unlawful orders,” were also cited as problematic.
• Internal DOJ Opposition: The nomination has faced significant pushback from within the Justice Department itself, with over 1,200 employees reportedly voicing their opposition.

“For these reasons, I will vote against this nomination,” Collins stated definitively.

Confirmation Hurdles and Republican Divisions

Senator Collins’s defection represents a significant, though not necessarily fatal, blow to the Trump administration’s efforts to confirm Blanche. In the evenly divided Senate, Republicans can only afford to lose one additional vote for the nomination to fail, especially with the continued absence of Senator Mitch McConnell, R-Ky., whose return date remains uncertain.

Beyond Collins, several other Republican senators have expressed reservations or have yet to commit to supporting Blanche. Senators Lisa Murkowski (R-Alaska), John Curtis (R-Utah), and Bill Cassidy (R-La.) are among those reportedly hesitant, adding to the growing list of potential obstacles.

This situation arises despite a prior agreement reached between Blanche, the Department of Justice, and Senators Thom Tillis, R-N.C., and John Cornyn, R-Texas. This deal, struck to secure their support in the Senate Judiciary Committee, reportedly stipulated that the “anti-weaponization” fund would be abandoned and that the scope of audit immunity for the Trump family would be narrowed. However, critics argue that the agreement lacks robust enforcement mechanisms, leaving open the possibility that such provisions could be disregarded post-confirmation.

Impact on Senate Schedule

The opposition from Senator Collins and the lingering doubts from other Republicans complicate the plans of Senate Majority Leader John Thune, R-S.D., and other GOP leaders who had aimed for a swift confirmation process before the upcoming August recess. The uncertainty surrounding Blanche’s nomination now casts a shadow over the Senate’s legislative agenda for the coming weeks.

As of this report, the White House had not immediately provided comment regarding Senator Collins’s decision.